Detalhe da pesquisa
1.
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc.
Retrovirology
; 13(1): 74, 2016 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27809912
2.
Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.
Retrovirology
; 11: 48, 2014 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24957778
3.
Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.
Retrovirology
; 10: 98, 2013 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24041034
4.
Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 Antagonists.
AIDS Res Hum Retroviruses
; 33(12): 1220-1235, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28797170
5.
Molecular Gymnastics: Mechanisms of HIV-1 Resistance to CCR5 Antagonists and Impact on Virus Phenotypes.
Curr Top Med Chem
; 16(10): 1091-106, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26324043
6.
Quantifying susceptibility of CD4+ stem memory T-cells to infection by laboratory adapted and clinical HIV-1 strains.
Viruses
; 6(2): 709-26, 2014 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24517971
7.
Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection.
PLoS One
; 8(6): e65950, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23824043